Why the study?
Does exogenous CTRP3 replenishment improve postischemic cardiac remodeling and cardiac dysfunction in a mouse model of myocardial infarction?
Population
Male adult mice subjected to myocardial infarction via left anterior descending coronary artery occlusion…
Comparison
Exogenous CTRP3 replenishment vs Control (not explicitly described in abstract)
Design
Preclinical
Authors
Loading...
CTRP3 merits testing as post-MI therapy in larger models; leaves open translation to human trials.
Does exogenous CTRP3 replenishment improve postischemic cardiac remodeling and cardiac dysfunction in a mouse model of myocardial infarction?
CTRP3 is a novel antiapoptotic, proangiogenic, and cardioprotective adipokine that improves survival and cardiac remodeling after myocardial infarction in a preclinical mouse model.
Yi et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: